Since December 2019, a new virus of the coronavirus family, named SARS-COV-2, has
spread throughout the world, being classified as “pandemic” and generating the so-called …

Abstract The coronavirus disease (COVID-19) is a global pandemic that significantly impacts
people living with diabetes. Diabetes-related factors of glycemic control, medication …

The population with diabetes is more susceptible to severe acute respiratory syndrome-
associated coronavirus (SARS-CoV)-2, and have a significantly higher coronavirus disease …

Main objective To determine how and to what extent COVID-19 has affected real-world, self-
reported glycaemic management in Americans with type 1 or type 2 diabetes taking insulin …

Patients with “post-COVID” syndrome manifest with a variety of signs and symptoms that
continue/develop after acute COVID-19. Among the most common are gastrointestinal (GI) …

Backgrounds. Diabetes mellitus (DM) is one of the most common comorbidities in patients
with coronavirus disease (COVID‐19). We aim to summarize the clinical features of DM …

Aim Diabetes has been identified as a risk factor for poor outcomes in patients with COVID‐
19. We examined the association of hyperglycaemia, both in the presence and absence of …

(1) Background: Clostridioides difficile (C. difficile) and SARS-CoV-2 coronavirus represent
significant health threats. Our study focused on the impact of concurrent infections on patient …

Background Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection
results in a spectrum of clinical presentations. The effect of co-infection with parasites on the …

Цель исследования-изучить особенности клинического течения COVID-19 при наличии
сахарного диабета (СД), а также возможные причины их взаимного отягощения …